Literature DB >> 30035647

Mosaicism in autoinflammatory diseases: Cryopyrin-associated periodic syndromes (CAPS) and beyond. A systematic review.

Marielle Labrousse1, Charlotte Kevorkian-Verguet2, Guilaine Boursier1, Dorota Rowczenio3, François Maurier4, Estibaliz Lazaro5, Manjari Aggarwal6, Irène Lemelle7, Thibault Mura8, Alexandre Belot2, Isabelle Touitou1, Guillaume Sarrabay1.   

Abstract

Autoinflammatory diseases (AIDs) are conditions related to defective regulation of the innate immune system. Sanger sequencing of the causative genes has long been the reference for confirming the diagnosis. However, for many patients with a typical AID phenotype, the genetic cause remains unknown. A pioneering study in 2005 demonstrated mosaicism in patients with cryopyrin-associated periodic syndromes (CAPS); the authors found somatic mosaicism in 69% of their cohort of Sanger-negative CAPS patients. We aim to address the extent to which mosaicism contributes to the etiology of AIDs and its impact on phenotype. We retrieved English-language publications reporting mosaicism in AIDs by querying PubMed with no restriction on date and we surveyed French reference centers. We provide a comprehensive clinical and genetic picture of mosaicism in AIDs. We estimate that the proportion of CAPS-like patients presenting mosaicism ranges from 0.5% to 19%. We also discuss the possible links between the proportion of mutated alleles and various clinical features. This review reevaluates the contribution of mosaic DNA variants in CAPS. Mosaicism may be more common than anticipated in other AIDs. No significant difference was demonstrated between variant allele frequency and clinical phenotype. Such knowledge has implications for the development of guidelines for genetic diagnosis, genetic counseling of affected families and effective patient care.

Entities:  

Keywords:  CAPS; autoinflammatory disease; mosaicism; systematic review

Mesh:

Year:  2018        PMID: 30035647     DOI: 10.1080/10408363.2018.1488805

Source DB:  PubMed          Journal:  Crit Rev Clin Lab Sci        ISSN: 1040-8363            Impact factor:   6.250


  13 in total

1.  GSDMD drives canonical inflammasome-induced neutrophil pyroptosis and is dispensable for NETosis.

Authors:  Dhruv Chauhan; Dieter Demon; Lieselotte Vande Walle; Oonagh Paerewijck; Annalisa Zecchin; Leslie Bosseler; Karin Santoni; Rémi Planès; Silvia Ribo; Amelie Fossoul; Amanda Gonçalves; Hanne Van Gorp; Nina Van Opdenbosch; Filip Van Hauwermeiren; Etienne Meunier; Andy Wullaert; Mohamed Lamkanfi
Journal:  EMBO Rep       Date:  2022-07-28       Impact factor: 9.071

Review 2.  Novel mutation in the NRLP3 manifesting as an intermediate phenotype of cryopyrinopathies.

Authors:  Luciana B Paim-Marques; Amanda Cavalcante; Catherine Castro; Theresa L Wampler Muskardin; João Bosco de Oliveira; Timothy B Niewold; Simone Appenzeller
Journal:  Rheumatol Int       Date:  2020-08-19       Impact factor: 2.631

Review 3.  Monogenic Autoinflammatory Diseases: State of the Art and Future Perspectives.

Authors:  Giulia Di Donato; Debora Mariarita d'Angelo; Luciana Breda; Francesco Chiarelli
Journal:  Int J Mol Sci       Date:  2021-06-14       Impact factor: 5.923

Review 4.  Current and future advances in genetic testing in systemic autoinflammatory diseases.

Authors:  Oskar Schnappauf; Ivona Aksentijevich
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

Review 5.  Hereditary systemic autoinflammatory diseases and Schnitzler's syndrome.

Authors:  Mark Kacar; Shelly Pathak; Sinisa Savic
Journal:  Rheumatology (Oxford)       Date:  2019-11-01       Impact factor: 7.580

Review 6.  Hints for Genetic and Clinical Differentiation of Adult-Onset Monogenic Autoinflammatory Diseases.

Authors:  Carla Gaggiano; Donato Rigante; Antonio Vitale; Orso Maria Lucherini; Alessandra Fabbiani; Giovanna Capozio; Chiara Marzo; Viviana Gelardi; Salvatore Grosso; Bruno Frediani; Alessandra Renieri; Luca Cantarini
Journal:  Mediators Inflamm       Date:  2019-12-31       Impact factor: 4.711

7.  Computational Modeling of NLRP3 Identifies Enhanced ATP Binding and Multimerization in Cryopyrin-Associated Periodic Syndromes.

Authors:  Jenny Mae Samson; Dinoop Ravindran Menon; Prasanna K Vaddi; Nazanin Kalani Williams; Joanne Domenico; Zili Zhai; Donald S Backos; Mayumi Fujita
Journal:  Front Immunol       Date:  2020-11-19       Impact factor: 7.561

Review 8.  Diagnosis and Management of the Cryopyrin-Associated Periodic Syndromes (CAPS): What Do We Know Today?

Authors:  Tatjana Welzel; Jasmin B Kuemmerle-Deschner
Journal:  J Clin Med       Date:  2021-01-01       Impact factor: 4.241

9.  Uncovering Low-Level Maternal Gonosomal Mosaicism in X-Linked Agammaglobulinemia: Implications for Genetic Counseling.

Authors:  Jacques G Rivière; Clara Franco-Jarava; Mónica Martínez-Gallo; Aina Aguiló-Cucurull; Laura Blasco-Pérez; Ida Paramonov; María Antolín; Andrea Martín-Nalda; Pere Soler-Palacín; Roger Colobran
Journal:  Front Immunol       Date:  2020-02-12       Impact factor: 7.561

Review 10.  Human Autoinflammatory Diseases Mediated by NLRP3-, Pyrin-, NLRP1-, and NLRC4-Inflammasome Dysregulation Updates on Diagnosis, Treatment, and the Respective Roles of IL-1 and IL-18.

Authors:  Sara Alehashemi; Raphaela Goldbach-Mansky
Journal:  Front Immunol       Date:  2020-08-25       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.